Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 45.50M | £ 33.70M | £ 32.70M | £ 22.30M | £ 10.50M |
Total Assets | £ 94.50M | £ 83.50M | £ 80.70M | £ 70.20M | £ 55.10M |
Total Debt | £ 5.00M | £ 5.40M | £ 5.80M | £ 6.20M | £ 6.40M |
Net Debt | £ -40.50M | £ -28.30M | £ -26.90M | £ -16.10M | £ -4.10M |
Total Liabilities | £ 50.50M | £ 48.50M | £ 49.90M | £ 45.40M | £ 42.10M |
Stockholders Equity | £ 44.00M | £ 35.00M | £ 30.80M | £ 24.80M | £ 13.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |